Michael Tuttle, MD | Authors

Articles

Dr. Michael Tuttle on Dosimetry Versus Empiric Dosing Radioactive Iodine Treatment

October 23, 2015

Michael Tuttle, MD, endocrinologist Memorial Sloan Kettering (MSK), discusses best management approaches to radioactive iodine treatment in patients with radioiodine avid distant metastases from differentiated thyroid cancer.